Patents by Inventor Roger Joyeau

Roger Joyeau has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Alkaloid compounds and their use as anti-malarial drugs
    Patent number: 7943633
    Abstract: Anti-malarial alkyloid compounds have the formula: wherein R1-R11 have various disclosed values or their pharmaceutically acceptable salts, and pharmaceutical compositions containing the same.
    Type: Grant
    Filed: October 20, 2006
    Date of Patent: May 17, 2011
    Assignees: Universite Pierre et Marie Curie (Paris VI), Centre National de la Recherche Scientifique, Museum National d'Histoire Naturelle, Institut Malgache de Recherche Appliquee
    Inventors: François Frappier, Marie-Pierre Frappier, legal representative, Jérôme Frappier, legal representative, Dominique Mazier, Maëlle Carraz, Jean-François Franetich, Akino Jossang, Roger Joyeau, Phillippe Rasoanaivo
  • Alkaloid compounds and their use as anti-malarial drugs
    Publication number: 20080038390
    Abstract: Anti-malarial alkyloid compounds have the formula: wherein R1-R11 have various disclosed values or their pharmaceutically acceptable salts, and pharmaceutical compositions containing the same.
    Type: Application
    Filed: October 20, 2006
    Publication date: February 14, 2008
    Inventors: Francois Frappier, Marie-Pierre Frappier, Jerome Frappier, Dominique Mazier, Maelle Carraz, Jean-Francois Franetich, Akino Jossang, Roger Joyeau, Phillippe Rasoanaivo
  • N-aryl-azetidinones, their preparation process and their use as elastase inhibitors
    Patent number: 5030628
    Abstract: The invention relates to N-aryl-azetidinones, their preparation process and their use as active serine elastase inhibitors.The N-aryl-azetidinones are in accordance with formula: ##STR1## in which R.sup.1 and R.sup.2 can be a halogen atom or an organic radical, R.sup.3 represents a halogen atom or another good starting group and R.sup.4 represents H or an organic radical.The compounds with R.sup.3 .dbd.Cl or OSO.sub.2 CH.sub.3, R.sup.4 .dbd.H and R.sup.1 .dbd.R.sup.2 .dbd.F or R.sup.1 .dbd.F and R.sup.2 .dbd.Br are irreversible and selective elastase inhibitors.
    Type: Grant
    Filed: December 19, 1989
    Date of Patent: July 9, 1991
    Assignee: Scientifique
    Inventors: Roger Joyeau, Randa Kobaiter, Michel Wakselman, Michele Reboud